A drafting checklist for chemical and pharmaceutical applications
Chemical and pharmaceutical patent applications can be challenging to draft because the experimental work available at the filing date may cover only some of the scope that we would like to claim. European patent applications should nevertheless contain enough information to allow the skilled person to carry out the invention and to justify sensible generalization beyond particular examples. The following checklist offers practical advice for addressing these drafting challenges.
1. Define the invention clearly and make sure claim amendments are available
An application should first make clear what the invention is and provide sufficient information for the skilled person to put it into practice. In chemical cases, this normally means defining compounds or compositions in meaningful structural or compositional terms. If non-standard parameters are used to define the invention, the method by which they are determined should also be clearly defined in the application. As in any patent application, the description and dependent claims of chemistry and pharma/biotech applications must contain good fallback options.
Essential: Explain any non-standard parameters, assays or measurement methods sufficiently for the skilled person to understand and reproduce them. Include narrower preferred ranges, substituent groups and combinations of features that can be used as claim amendments if the broadest claim cannot be maintained.
2. Use examples that support reasonable generalization
Broad claims are not inherently problematic. A claim to a chemical genus, for example, does not require every possible compound within the genus to have been prepared and tested. Nevertheless, the broader and less predictable the claimed subject matter becomes, the more support is needed. Very broad Markush formulae or wide numerical ranges can be vulnerable to objections if the examples given in the description concern only a narrow part of the claimed scope.
There is no universal answer to how many examples are enough. Ten almost identical examples may provide less support for a broad claim than three significantly different ones. Strong support for the intended generalization may be provided by examples covering different parts of the claimed scope, together with general preparation methods, analytical characterization, and data demonstrating the intended activity or effect.
Essential: Include enough experimental detail to make the examples reproducible.
Where available: Include examples covering different structural alternatives and compositions. For a wide structural or numerical range, examples towards different parts of the range can provide very useful support for generalization.
3. If possible, identify relevant effects and provide appropriate support
Where a particular technical or advantageous effect is important to the invention, that effect should be identified in the application. The amount of support required depends on what is being asserted. An application claiming an improvement over known compounds may need a stronger evidential basis than an application which merely teaches a workable alternative. An explicit statement of the effect is not always required if the skilled person could derive it from the application using common general knowledge, but it’s much safer to be explicit.
Where available: Comparative examples, quantitative experimental data or other evidence supporting the underlying mechanism will usually be convincing if they can be included in the original application text. If possible, try to associate particular technical effects also with narrower groups of compounds, sub-ranges, or other preferred embodiments to support your fallback positions.
4. For therapeutic inventions, establish a credible link to the claimed treatment
Therapeutic inventions deserve particular attention because it is not normally sufficient simply to identify a compound and state that the compound can treat a disease. The application must provide a credible basis for the claimed therapeutic application. Depending on the circumstances, in vitro results, mechanistic evidence and established scientific knowledge may together provide sufficient support.
Essential: Include sufficient information in the application as filed to establish a link between the claimed compound or composition and the therapeutic effect. Further evidence can be generated after filing and may be useful during prosecution, but it should not be assumed that post-filed evidence can remedy an insufficient disclosure of the therapeutic effect in the application as filed (see decision G2/21, paragraph 77).
Where available: Include pharmacological, in vitro or in vivo results, dose-response information, and other evidence linking the compound to a mechanism involved in the disease.
5. Consider when to file, what to claim, and what supports your claim
Waiting until a perfect set of experimental evidence exists may take too long. When you decide to file an application, you should balance the claimed protection against the evidence you currently have and the evidence you expect to obtain in the future. Later post-published evidence may be submitted, but it generally cannot establish an effect for which the original application provides no basis.
You should therefore look in two directions: towards the broadest protection and possible technical effects that current and future experiments might support, and towards narrower positions that the present evidence comfortably supports.
Essential: Before filing, ask whether the current evidence provides sufficiently detailed support for the claimed scope and, particularly in therapeutic cases, the effect being claimed. If not, include narrower fallback positions that are clearly supported by the application as filed.
Where available: Include in your application preliminary, more speculative indications of possible benefits which may (or may not) be supported by future evidence.
Conclusion
Do the examples and information presented in your application text justify the step from “we have demonstrated that these embodiments work” to “the skilled person can reasonably expect the claimed invention to work more generally”?
The answer depends on (1) the technology, (2) the breadth of the claims, (3) the evidence available at the filing date, (4) how that evidence is presented in the application, and (5) what evidence might become available later on.
Bringing these elements together in a new patent application requires both technical understanding and experience of European patent practice. Patent attorneys specializing in chemistry, pharmaceuticals and biotechnology can help applicants find the optimal balance between claim breadth, experimental support and effective fallback positions.
Latest blog articles
From idea to market – which patent analysis do you need?
A drafting checklist for chemical and pharmaceutical applications
Egg carton illustrates how to package inventions for the Unified Patent Court
When a Descriptive Trademark Comes at a Cost: The SÄHKÖMESSUT Case
Sufficiency at the EPO: two recent cases
Writer